The French pharma major has started a $15.50 per share cash tender offer for Emeryville, California-based Dynavax, which ...

In the latest of a flurry of announcements ahead of the holiday period, CMS has revealed a new, voluntary access programme ...

In labs, water consumption and single-use plastics like pipette tips can contribute to environmental impact. Lab equipment ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...

It's notable that Ipsen has bolted on more than 20 early-stage programmes since 2020 as part of a push to become a major ...

The FDA has delivered a gift to Novo Nordisk ahead of the holiday season, with the prompt approval of an oral formulation of ...

AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US in light of FDA concerns ...

The ACIP has been accused of cherry-picking data on side effects – attempting to perpetuate a debunked link between the shots ...

Distilling that complexity into a handful of trends has been no small task. What follows is not a definitive forecast, but ...

Compared to Sotyktu (deucravacitinib), which was approved by the FDA for plaque psoriasis in 2022 and brought in sales of ...

The green light for Rybrevant Faspro – which combines amivantamab with hyaluronidase – means that the drug is the first ...